« Abbott Moves to Block Many Biosimilar Applications | Main | Pharma R&D Follies »

04/25/2012

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a0120a77f675b970b016304bd696a970d

Listed below are links to weblogs that reference Amgen warns biosimilar draft a threat to production innovation:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

bigredbruce

More comments on other drug company comments on proposed FDA biosimilar guidelines
http://blog.pharmtech.com/2012/04/25/a-few-comments-on-the-comments/

The comments to this entry are closed.

My Photo
Blog powered by Typepad
Member since 12/2009
Bookmark and Share

August 2014

Sun Mon Tue Wed Thu Fri Sat
          1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30
31            

Innovate on Purpose

In the Pipeline

Life Sci VC


visited 6 states (46.1%)
Create your own visited map of Canada